This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
Ziftomenib (KO-539) is an oral menin-MLL1 protein-protein interaction inhibitor being developed for acute myeloid leukemia (AML) by Kura Oncology. This…
molecule
7 months ago ●
3 mins read
In June 2022, the FDA approved vutrisiran (Amvuttra), a small interfering RNA (siRNA) for polyneuropathy of hereditary transthyretin-mediated (ATTR) amyloidosis…
Article
1 year ago ●
6 mins read
Mavacamten is a first-in-class oral, selective, allosteric cardiac myosin inhibitor, discovered by Myokardia and acquired by BMS in 2020 in…
molecule
7 months ago ●
2 mins read
In the early 90’s, Wayne (Haifeng) Tang and Ray Zhao formed a friendship in high school in China. They were…
Article
1 year ago ●
2 mins read
Voxelotor is a first-in-class, reversible covalent aldehyde drug that prevents the hemoglobin polymerization, a primary driver of sickle cell disease.…
molecule
7 months ago ●
2 mins read
A first-in-class intravenous kappa opioid receptor (KOR) agonist, an oral soluble guanylate cyclase (sGC) stimulator, a first-in-class subcutaneous complement C3…
Article
1 year ago ●
15 mins read
Load More
